Last reviewed · How we verify
NCT06671769
Natural Heart Health Supplement Trial
Phase 1 trial testing Heart Health Supplement in Cholesterol in 60 participants. Not yet recruiting.
30 April 2025
Quick facts
| Lead sponsor | Efforia, Inc |
|---|---|
| Phase | Phase 1 |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 15 January 2025 |
| Primary completion | 30 April 2025 |
| Estimated completion | 1 May 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Heart Health Supplement
Conditions studied
- Cholesterol — all drugs for Cholesterol →
- Cholesterol (total and HDL) — all drugs for Cholesterol (total and HDL) →
Sponsor
Efforia, Inc — full company profile →
Who can join
21 and older, any sex, with Cholesterol or Cholesterol (total and HDL). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
We are running a 3-month trial of an experimental natural heart health supplement. Participants will take a daily dose of an experimental natural heart health supplement in powdered format, chocolate flavor. The trial will assess changes in heart biomarkers such as Total Cholesterol, HDL-C, LDL-C, Triglycerides, and High-Sensitivity C-reactive protein (hs-CRP).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06671769
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cholesterol
Currently open trials in the same condition.
- NCT06919302 — The Effect of a Digital Heart Health App and Lifestyle Intervention for Heart Disease in Primary Care. · NA · recruiting
- NCT07101263 — Whey Protein Comparisons for Blood Lipid Effects · NA · recruiting
- NCT05050266 — Enhancing Mental and Physical Health of Women Veterans · NA · active not recruiting
- NCT07252830 — Identification of Asymptomatic Patients at Very High Cardiovascular Risk: Contribution of a Strategy Based on Carotid an · recruiting
Other Efforia, Inc trials
Trials by the same sponsor.
- NCT07477223 — Beef Versus Whey Protein: The Gut Showdown Self-Experiment · NA · recruiting
- NCT07477236 — MyVitalC: Sleep and Everyday Headache Management · NA · recruiting
- NCT07282275 — How Does Continued Use of Green Light Therapy Impact Outcomes? · NA · recruiting
- NCT07478497 — 30 Day Insulin Balance Metabolic Health Optimization Protocol · NA · recruiting
- NCT07256639 — Evaluating Heart & Soil's Whole Package on Men's Health · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06671769 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Efforia, Inc
- Last refreshed: 4 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06671769.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing